Form 4: Altimmune CFO Receives Stock Grant
Insider Transaction (Form 4)
Gregory L Weaver, Chief Financial Officer of Altimmune, Inc., received 1,753 shares of common stock on July 31, 2026.
Summary
- Grant/award: acquired 1,753 Common Stock, par value $0.0001 at $2.41 ($4,232) on July 31, 2026; holds 39,831 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Gregory L Weaver — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-31 | Grant/award | Common Stock, par value $0.0001 | 1,753 | $2 | $4.2K | 39,831 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-31 | Grant/award (1,753 shares) |
Keywords
insider transaction, Form 4, ALT, Altimmune, Inc., neutral, Gregory L Weaver
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.